Physician

Adriana Dejman Valdez, M.D

According to 2025 Medicare claims, Adriana Valdez, M.D (NPI: 1689937567) practices nephrology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is UNIVERSITY OF MIAMI (NPI: 1760434286; TIN: 592579938) and primary practice location at 33136-1121.

Valdez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 233 traditional Medicare patients, billed 694 HCPCS/CPT codes, and received $102,067 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 624 prescription claims across 92 beneficiaries totaling $99,713 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2016 DME data shows 27 claims. Open Payments data shows 3 records totaling $67. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $36,439 and ending at $102,067. Concurrently, Part D prescription costs have risen steadily, from $57,851 to $99,713. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	125	279	$36,439
2018	329	1,180	$151,993
2019	309	574	$73,021
2020	227	502	$60,034
2021	266	755	$97,202
2022	188	413	$55,434
2023	226	711	$102,955
2024	233	694	$102,067

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	506	$57,851
2016	35	232	$20,697
2017	30	82	$12,461
2018	62	311	$42,587
2019	81	391	$71,065
2020	85	380	$54,850
2021	69	473	$51,040
2022	61	399	$45,479
2023	71	508	$67,812
2024	92	624	$99,713

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	27	$4,222
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	36	36	$135
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	23	23	$126
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	95	220	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	37	52	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	51	68	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	15	450	$20,030
Farxiga	Dapagliflozin Propanediol	15	990	$18,744
Jardiance	Empagliflozin	12	900	$17,125
Sevelamer Carbonate	Sevelamer Carbonate	27	1,335	$6,444
Nifedipine Er	Nifedipine	40	2,460	$1,079

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$67	AKEBIA THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adriana Dejman Valdez, M.D?

Tedicare shows public-source Medicare data for Adriana Dejman Valdez, M.D (NPI 1689937567), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana Dejman Valdez, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adriana Dejman Valdez, M.D?

Adriana Dejman Valdez, M.D is linked to UNIVERSITY OF MIAMI (billing NPI 1760434286) in the available physician profile data.

Does Adriana Dejman Valdez, M.D have Open Payments data?

Adriana Dejman Valdez, M.D has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.